Synthesising licensing data to assess drug safety

Documenti analoghi

• Where are we now with hormone replacement therapy?: It works for symptoms but is not good for future health
  di: McPherson, Klim
  Pubblicazione: (2004)
• Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle
  di: Taylor, R S, et al.
  Pubblicazione: (2004)
• Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials.
  di: Hemminki, E., et al.
  Pubblicazione: (1997)
• The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development
  di: Walker, D K
  Pubblicazione: (2004)
• Assessing Drug Safety in Children — The Role of Real-World Data
  di: McMahon, Ann W., et al.
  Pubblicazione: (2018)